Eva Colas Ortega I am principal researcher in the Group of Biomedical Research in Gynecology, where I lead the translational research group. My research interest is to provide solutions for unmet clinical needs in gynecology, mainly in endometrial cancer and endometriosis. We work on biomarker research to provide with innovative solutions and preclinical models to improve personalized medicine. Institutions of which they are part Head of group Biomedical Research in Gynaecology Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Eva Colas Ortega LinkedIn Twitter Orcid Institutions of which they are part Head of group Biomedical Research in Gynaecology Vall Hebron Institut de Recerca I am principal researcher in the Group of Biomedical Research in Gynecology, where I lead the translational research group. My research interest is to provide solutions for unmet clinical needs in gynecology, mainly in endometrial cancer and endometriosis. We work on biomarker research to provide with innovative solutions and preclinical models to improve personalized medicine.
I am biologist by formation and fully dedicated to endometrial cancer research for the last 16 years. From 2017, I lead my own team in the Group of Biomedical Research in Gynecology (VHIR) and my research focus on the implementation of molecular diagnostics and personalized medicine in gynecology, mainly in endometrial cancer (EC) and endometriosis. In my career I participated in the development of the first EC patient-derived murine models (PDX), and today, my group owns one of the largest PDX biobanks in Europe, which is used by us, partners and pharma to assess treatments for EC patients. Importantly, I have also grown as a scientist dedicated to biomarker research in gynecological fluids. I worked in the development of the first molecular kit to diagnose EC. Today, I am the European Coordinator of a multicenter study to develop a non-invasive diagnosis of EC (ERA PerMed), and am the founder of a spin-off (MiMARK Diagnostics S.L.) that aims to develop innovative solutions for women health. As a summary, I have a total of 73 scientific articles with impact factor; 17 of them as senior author; and am inventor of 4 patents. My scientific and leadership capacity is proved by the supervision of 12 doctoral theses, 6 of which have already been defended, two of them awarded. I have participated in 32 competitive research projects, being 13 of them principal investigator, and I am actively participating in national (CIBERONC) and international (ENITEC) cancer networks. I have been teaching in graduate and master studies for the last 7 years; and I have been on the Steering Committee of the Societat Catalana de Biologia for 10 years.
Projects Desarrollo de una herramienta de diagnóstico precoz de cáncer de endometrio en biopsia líquida cervical IP: Eva Colas Ortega Collaborators: Vicente Bebia Conesa, Maria Cristina Centeno Mediavilla, Silvia Franco Camps, Silvia Cabrera Diaz Funding agency: Instituto de Salud Carlos III Funding: 93170 Reference: PI17/02155 Duration: 01/01/2018 - 30/06/2022 Desarrollo de una herramienta molecular para el diagnóstico y pronóstico en cáncer de endometrio IP: Antonio Gil Moreno Collaborators: Angel García Jiménez, Eva Colas Ortega, Silvia Cabrera Diaz Funding agency: Instituto de Salud Carlos III Funding: 85250 Reference: DTS17/00146 Duration: 01/01/2018 - 31/12/2020 NUEVAS ESTRATEGIAS PARA INCREMENTAR EFICACIA DE LOS TRATAMIENTOS CON ABTL0812 IP: Eva Colas Ortega Collaborators: - Funding agency: Ministerio Economía, Industria y Competitividad Funding: 187760 Reference: RTC-2017-6261-1 Duration: 01/01/2018 - 31/10/2021 CEMARK: Molecular tool to diagnose endometrial cancer IP: Eva Colas Ortega Collaborators: Zapata Guardiola, Rebeca Funding agency: Fundació "La Caixa" Funding: 70000 Reference: CI16-00023/CEMARK Duration: 01/09/2016 - 31/12/2018 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page »
